Genomic Diversity and Antimicrobial Resistance of Vibrio cholerae Isolates from Africa: A PulseNet Africa Initiative Using Nanopore Sequencing to Enhance Genomic Surveillance
Gespeichert in:
| Veröffentlicht in: | bioRxiv (Jan 4, 2025) |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Veröffentlicht: |
Cold Spring Harbor Laboratory Press
|
| Schlagworte: | |
| Online-Zugang: | Citation/Abstract Full Text - PDF Full text outside of ProQuest |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
MARC
| LEADER | 00000nab a2200000uu 4500 | ||
|---|---|---|---|
| 001 | 3151472849 | ||
| 003 | UK-CbPIL | ||
| 022 | |a 2692-8205 | ||
| 024 | 7 | |a 10.1101/2024.12.17.628868 |2 doi | |
| 035 | |a 3151472849 | ||
| 045 | 0 | |b d20250104 | |
| 100 | 1 | |a Foster-Nyarko, Ebenezer | |
| 245 | 1 | |a Genomic Diversity and Antimicrobial Resistance of Vibrio cholerae Isolates from Africa: A PulseNet Africa Initiative Using Nanopore Sequencing to Enhance Genomic Surveillance | |
| 260 | |b Cold Spring Harbor Laboratory Press |c Jan 4, 2025 | ||
| 513 | |a Working Paper | ||
| 520 | 3 | |a Objectives: Vibrio cholerae remains a significant public health threat in Africa, with antimicrobial resistance (AMR) complicating treatment. This study leverages whole-genome sequencing (WGS) of V. cholerae isolates from Cote d'Ivoire, Ghana, Zambia and South Africa to assess genomic diversity, AMR profiles, and virulence, demonstrating the utility of WGS for enhanced surveillance within the PulseNet Africa network. Methods: We analysed Vibrio isolates from clinical and environmental sources (2010-2024) using Oxford Nanopore sequencing and hybracter assembly. Phylogenetic analysis, multilocus sequence typing (MLST), virulence and AMR gene detection were performed using Terra, Pathogenwatch, and Cloud Infrastructure for Microbial Bioinformatics (CLMB) platforms, with comparisons against 88 global reference genomes for broader genomic context. Results: Of 79 high-quality assemblies, 67 were confirmed as V. cholerae, with serogroup O1 accounting for the majority (43/67, 67%). ST69 accounted for 60% (40/67) of isolates, with eight sequence types identified overall. Thirty-seven isolates formed novel sub-clades within AFR12 and AFR15 O1 lineages, suggesting local clonal expansions. AMR gene analysis revealed high resistance to trimethoprim (96%) and quinolones (83%), while resistance to azithromycin, rifampicin, and tetracycline remained low (less than or equal to 7%). A significant proportion of the serogroup O1 isolates (41/43, 95%) harboured resistance genes in at least three antibiotic classes. Conclusions: This study highlights significant genetic diversity and AMR prevalence in African V. cholerae isolates, with expanding AFR12 and AFR15 clades in the region. The widespread resistance to trimethoprim and quinolones raises concerns for treatment efficacy, although azithromycin and tetracycline remain viable options. WGS enables precise identification of species and genotyping, reinforcing PulseNet Africa's pivotal role in advancing genomic surveillance and enabling timely public health responses to cholera outbreaks.Competing Interest StatementThe authors have declared no competing interest.Footnotes* New file with figures and legends uploaded.* https://doi.org/10.6084/m9.figshare.27941376.v1 | |
| 651 | 4 | |a Africa | |
| 653 | |a Genotyping | ||
| 653 | |a Public health | ||
| 653 | |a Quinolones | ||
| 653 | |a Bioinformatics | ||
| 653 | |a Virulence | ||
| 653 | |a Antimicrobial resistance | ||
| 653 | |a Antimicrobial agents | ||
| 653 | |a Whole genome sequencing | ||
| 653 | |a Surveillance | ||
| 653 | |a Rifampin | ||
| 653 | |a Multilocus sequence typing | ||
| 653 | |a Azithromycin | ||
| 653 | |a Genomics | ||
| 653 | |a Drug resistance | ||
| 653 | |a Genetic diversity | ||
| 653 | |a Trimethoprim | ||
| 653 | |a Vibrio cholerae | ||
| 700 | 1 | |a Able-Thomas, Shola | |
| 700 | 1 | |a Adade, Nana Eghele | |
| 700 | 1 | |a Adade, Rexford | |
| 700 | 1 | |a Jean Claude Blessa Anne | |
| 700 | 1 | |a Antwi, Loretta | |
| 700 | 1 | |a Bah, Yaya | |
| 700 | 1 | |a Boateng, Gifty | |
| 700 | 1 | |a Carleton, Heather | |
| 700 | 1 | |a Chaima, David | |
| 700 | 1 | |a Chilengi, Roma | |
| 700 | 1 | |a Kalpy Julien Coulibaly | |
| 700 | 1 | |a Firehiwot Abera Derra | |
| 700 | 1 | |a Didon, Dwayne | |
| 700 | 1 | |a Dimuna, Cheelo | |
| 700 | 1 | |a Dosso, Mireille | |
| 700 | 1 | |a Drammeh, Momodou M | |
| 700 | 1 | |a Ferjani, Sana | |
| 700 | 1 | |a Holt, Kathryn E | |
| 700 | 1 | |a Jatta, Rohey | |
| 700 | 1 | |a John Bosco Kalule | |
| 700 | 1 | |a Kanteh, Abdoulie | |
| 700 | 1 | |a Kette, Hortense Faye | |
| 700 | 1 | |a Khan, Dam | |
| 700 | 1 | |a N'da Kouame Nazaire Kouadio | |
| 700 | 1 | |a Lee, Christine | |
| 700 | 1 | |a Mantina, Hamakwa | |
| 700 | 1 | |a Mulenga, Gillan | |
| 700 | 1 | |a Mwaba, John | |
| 700 | 1 | |a Nyang, Fatou | |
| 700 | 1 | |a Owusu-Okyere, Godfred | |
| 700 | 1 | |a Rowland, Jessica | |
| 700 | 1 | |a Seck, Aissatou | |
| 700 | 1 | |a Abdul Karim Sesay | |
| 700 | 1 | |a Smith, Anthony | |
| 700 | 1 | |a Smith, Peyton | |
| 700 | 1 | |a Djifahamai Soma | |
| 700 | 1 | |a Tau, Nomsa | |
| 700 | 1 | |a Pierrette Landrie Simo Tchuint | |
| 700 | 1 | |a Peggy-Estelle, Maguiagueu Tientcheu | |
| 700 | 1 | |a Sokoni, Chalwe | |
| 700 | 1 | |a Sabine N'dri Vakou | |
| 700 | 1 | |a Delfino Vubil | |
| 700 | 1 | |a Africa, Pulsenet | |
| 773 | 0 | |t bioRxiv |g (Jan 4, 2025) | |
| 786 | 0 | |d ProQuest |t Biological Science Database | |
| 856 | 4 | 1 | |3 Citation/Abstract |u https://www.proquest.com/docview/3151472849/abstract/embedded/75I98GEZK8WCJMPQ?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text - PDF |u https://www.proquest.com/docview/3151472849/fulltextPDF/embedded/75I98GEZK8WCJMPQ?source=fedsrch |
| 856 | 4 | 0 | |3 Full text outside of ProQuest |u https://www.biorxiv.org/content/10.1101/2024.12.17.628868v2 |